Matthew Herper covers medical innovation — both its promise and its perils. A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap ...

This order makes it the policy of the United States to have the most-favored-nation price for prescription drugs and biologics. The order directs the Secretary of Commerce and the United States ...

which Salk biologists are investigating for its potential foundation in a neurological drug for Alzheimer’s disease. In the case of the latter two, Native Americans have used them traditionally ...

New data tool shows out-of-pocket costs have increased for most drugs targeted by Inflation Reduction Act price controls A new data tool from Pioneer Institute reveals that federal drug price ...

A new data tool from Pioneer Institute reveals that federal drug price controls—intended to reduce out-of-pocket costs for seniors—are instead making many prescription drugs more expensive for ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy.

The topline results are from ACHIEVE-1, the first phase III trial of an oral GLP-1 drug to successfully reach completion, a press release notes. Taken as a once-daily pill, orforglipron, unlike oral ...

Methods: Spontaneous reports were excavated from the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS) database from Q1 2004 to Q2 2024. Adverse reaction signals of ...

This integration brings AI-driven computational drug discovery directly into Sapio ELN (Electronic Lab Notebook), helping to streamline workflows and improve decision-making in drug discovery.

With the BioNeMo platform, researchers can accelerate drug discovery by leveraging science-specific AI frameworks, pre-trained models, and generative AI tools to streamline the identification of ...